Provider
P53-21 Update for New-to-Market Medical Drug: aducanumab (Aduhelm)
Program effective Date: Oct 01, 2021
Program effective Date: Oct 01, 2021
Program effective Date: Oct 01, 2021
Program effective Date: Oct 01, 2021
Program effective Date: Oct 01, 2021